Provided by Tiger Trade Technology Pte. Ltd.

Corgi TEM 2x Daily ETF

31.42
+0.07430.24%
Post-market: 31.35-0.0743-0.24%16:10 EDT
Volume:48
Turnover:2K
Market Cap:471.30K
PE:- -
High:31.42
Open:31.35
Low:31.42
Close:31.35
52wk High:39.36
52wk Low:10.77
Shares:15.00K
Float Shares:15.00K
Volume Ratio:0.26
T/O Rate:0.32%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Anthropic's IPO Filing Shows 47% Of Sales Running Through Amazon And Google — Investors, Suppliers And Rivals

AI Industry Frontlines
·
Sep 30

Who Pays For AI's Spending? Anthropic's IPO Filing Lays Bare A $4.2 Trillion Gap

AI Industry Frontlines
·
Sep 30

The $2.6 Trillion AI Shopping Shift: Who Wins When AI Decides What You Buy?

AI Industry Frontlines
·
Sep 30

AI’S New Arms Race: Anthropic’S SpaceX Deal Could Reach $84.5 Billion

AI Industry Frontlines
·
Sep 30

Trump Orders Federal Agencies Onto A Single AI Portal Within 90 Days, Consolidating 29,000 Government Websites

AI Industry Frontlines
·
Sep 30

Tempus AI Diagnostics CEO Thomas Edward Schoenherr Disposes of $873,885 in Common Shares

Reuters
·
Sep 30

Tempus AI Wins FDA Clearance for ECG-MR Tool to Flag Undiagnosed Mitral Regurgitation

Reuters
·
Sep 28

Tempus Receives FDA Clearance for Its Ecg-Mr AI Product Designed to Identify Undiagnosed Mitral Regurgitation

THOMSON REUTERS
·
Sep 28

A $10–12 Trillion Bubble With All Four Fuses Lit? The Chanos–Marcus Case Against AI

Analyst Calls
·
Sep 28

Tempus AI CEO and Chairman Eric P. Lefkofsky Disposes of $17,868,777.62 in Class a Shares

Reuters
·
Sep 25

Tempus AI Inc Stock (TEM) Closed Up by 7.38% on Sep 24: What Investors Need To Know

TradingKey
·
Sep 25

tempus AI Inc Class A call volume above normal and directionally bullish

TIPRANKS
·
Sep 25

Morgan Stanley: Semiconductors To Reach $1.5T In 2030, AI Semis ~50% Of The Pie

Analyst Calls
·
Sep 24

Analysts Have Conflicting Sentiments on These Healthcare Companies: Tempus AI, Inc. Class A (TEM) and Avantor (AVTR)

TIPRANKS
·
Sep 22

Recursion Licenses TxFM RNA Foundation Model to Tempus AI for Oncology Use in USD 12 Million Deal

Reuters
·
Sep 22

Tempus Extends Data Licensing Partnership with Recursion Through November 2029

Reuters
·
Sep 22

Tempus AI, Recursion Extend Data License, Amend Fee Structure

MT Newswires Live
·
Sep 21

Recursion, Tempus Expand AI and RNA Collaboration Agreements

TIPRANKS
·
Sep 21

Tempus AI, Recursion extend data license agreement, enter new license agreement

TIPRANKS
·
Sep 21

Tempus AI, - Recursion Grants Tempus Non-Exclusive Worldwide License to Rna Sequencing Model Txfm

THOMSON REUTERS
·
Sep 21